American Journal of Kidney Diseases
Volume 53, Issue 5 , Pages 804-814 , May 2009

Conversion of Vascular Access Type Among Incident Hemodialysis Patients: Description and Association With Mortality

  • Brian D. Bradbury, DSc, MA

      Affiliations

    • Department of Biostatistics and Epidemiology, Amgen Inc, Thousand Oaks, CA
    • Corresponding Author InformationAddress correspondence to Brian D. Bradbury, DSc, MA, 1 Amgen Center Dr, MS: 24-2-A, Thousand Oaks, CA 91320
    • ,
  • Fangfei Chen, MPH

      Affiliations

    • Department of Biostatistics and Epidemiology, Amgen Inc, Thousand Oaks, CA
    • ,
  • Anna Furniss, MS

      Affiliations

    • Colorado Health Institute, Denver, CO
    • ,
  • Ronald L. Pisoni, PhD, MS

      Affiliations

    • Arbor Research Collaborative for Health, Ann Arbor, MI
    • ,
  • Marcia Keen, PhD

      Affiliations

    • Medical Research Management, Amgen Inc, Thousand Oaks, CA
    • ,
  • Donna Mapes, PhD

      Affiliations

    • Arbor Research Collaborative for Health, Ann Arbor, MI
    • ,
  • Mahesh Krishnan, MD, MPH

      Affiliations

    • Medical Research Management, Amgen Inc, Thousand Oaks, CA

Received 13 May 2008 ,Accepted 20 November 2008.

References 

  1. No author listed: http://www.fistulafirst.org/“Change Concepts”. Accessed September 29, 2008
  2. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA. Hemodialysis vascular access morbidity in the United States. Kidney Int. 1993;43:1091–1096
  3. Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int. 2001;60:1–13
  4. Taylor GD, McKenzie M, Buchanan-Chell M, Caballo L, Chui L, Kowalewska-Grochowska K. Central venous catheters as a source of hemodialysis-related bacteremia. Infect Control Hosp Epidemiol. 1998;19:643–646
  5. Allon M. Dialysis catheter-related bacteremia: Treatment and prophylaxis. Am J Kidney Dis. 2004;44:779–791
  6. Ribot S, Siddiqi SW, Chen C. Right heart complications of dual lumen tunneled venous catheters in hemodialysis patients. Am J Med Sci. 2005;330:204–208
  7. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in US hemodialysis patients. Kidney Int. 2001;60:1443–1451
  8. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002;62:620–626
  9. Xue JL, Dahl D, Ebben JP, Collins AJ. The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis. 2003;42:1013–1019
  10. Rayner HC, Besarab A, Brown WW, Disney A, Saito A, Pisoni RL. Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): Performance Against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines. Am J Kidney Dis. 2004;44(suppl 2):S22–S26
  11. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: A propensity score analysis. J Am Soc Nephrol. 2004;15:477–486
  12. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J. Type of vascular access and survival among incident hemodialysis patients: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol. 2005;16:1449–1455
  13. Lorenzo V, Martin M, Rufino M, Hernandez D, Torres A, Ayus JC. Predialysis nephrologic care and a functioning arteriovenous fistula at entry are associated with better survival in incident hemodialysis patients: An observational cohort study. Am J Kidney Dis. 2004;43:999–1007
  14. Bradbury BD, Fissell RB, Albert JM, et al. Predictors of early mortality among incident United States hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2007;2:89–99
  15. US Renal Data System. USRDS 2006 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006;
  16. Centers for Medicare & Medicaid Services. 2006 Annual Report, End Stage Renal Disease Clinical Performance Measures Project. Baltimore, MD: Department of Health and Human Services, Centers for Medicare & Medicaid Services, Office of Clinical Standards & Quality; 2007;
  17. Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner MH, Wolfe RA. The Dialysis Outcomes and Practice Patterns Study (DOPPS): Design, data elements, and methodology. Am J Kidney Dis. 2004;44(suppl 3):S7–S15
  18. Young EW, Goodkin DA, Mapes DL, et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international HD study. Kidney Int Suppl. 2000;74:S74–S81
  19. Klein JP, Moeschberger ML. Survival Analysis Techniques for Censored and Truncated Data. In: New York, NY: Springer; 1997;p. 417
  20. Johnston SC, Henneman T, McCulloch CE, van der Laan M. Modeling treatment effects on binary outcomes with grouped-treatment variables and individual covariates. Am J Epidemiol. 2002;156:753–760
  21. Astor BC, Eustace JA, Powe NR, et al. Timing of nephrologist referral and arteriovenous access use: The CHOICE Study. Am J Kidney Dis. 2001;38:494–501
  22. Stehman-Breen CO, Sherrard DJ, Gillen D, Caps M. Determinants of type and timing of initial permanent hemodialysis vascular access. Kidney Int. 2000;57:639–645
  23. Avorn J, Winkelmayer WC, Bohn RL, et al. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002;55:711–716
  24. Saran R, Elder SJ, Goodkin DA, et al. Enhancing training in creation of vascular accesses predicts arteriovenous fistula placement and patency in hemodialysis patients. Ann Surg. 2008;247:885–891
  25. Chand DH, Teo BW, Fatic RA, Brier M Medical Review Board of The Renal Network Inc. Influence of vascular access type on outcome measures in patients on maintenance hemodialysis. Nephron Clin Practice. 2008;108:c91–c98
  26. Allon M, Daugirdas J, Depner TA, Greene T, Ornt D, Schwab SJ. Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis. 2006;47:469–477
  27. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux on mortality and morbidity in maintenance hemodialysis patients: Primary results of the HEMO study. N Engl J Med. 2002;347:2010–2019
  28. Wasse H, Speckman RA, Frankenfield DL, Rocco MV, McClellan WM. Predictors of delayed transition from central venous catheter use to permanent vascular access among ESRD patients. Am J Kidney Dis. 2007;49:276–283
  29. Wang W, Murphy B, Yilmaz S, Tonelli M, MacRae J, Manns BJ. Comorbidities do not influence primary fistula success in incident hemodialysis patients: A prospective study. Clin J Am Soc Nephrol. 2008;3:78–84
  30. Dember LM, Beck GJ, Allon M, et al. Dialysis Access Consortium Study Group Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: A randomized controlled trial. JAMA. 2008;299:2164–2171
  31. Karakayali F, Basaran O, Ekici Y, et al. Effect of secondary intervention on patency of vascular access sites for hemodialysis. Eur J Vasc Endovasc Surg. 2006;32:701–709
  32. Woods JD, Turenne MN, Strawderman RL, et al. Vascular access survival among incident hemodialysis patients in the United States. Am J Kidney Dis. 1997;30:50–57
  33. Windus DW. The effect of comorbid conditions on hemodialysis access patency. Adv Ren Replace Ther. 1994;1:148–154
  34. Mendes RR, Farber MA, Marston WA, Dinwiddie LC, Keagy BA, Burnham SJ. Prediction of wrist arteriovenous fistula maturation with preoperative vein mapping with ultrasonography. J Vasc Surg. 2002;36:460–463
  35. Astor BC, Coresh J, Powe NR, Eustace JA, Klag MJ. Relation between gender and vascular access complications in hemodialysis patients. Am J Kidney Dis. 2000;36:1126–1134

 Originally published online as doi:10.1053/j.ajkd.2008.11.031 on March 6, 2009.

PII: S0272-6386(09)00031-6

doi: 10.1053/j.ajkd.2008.11.031

American Journal of Kidney Diseases
Volume 53, Issue 5 , Pages 804-814 , May 2009

Article Tools

* Image Usage & Resolution